Scarborough Advisors »

Lenz Therapeutics shares owned by Scarborough Advisors

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Scarborough Advisors from 13F filings

Historical chart of Scarborough Advisors investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Scarborough Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Scarborough Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $732 80 9.15

More positions owned by Scarborough Advisors

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
Blackrock Etf Trust Ishares Intl Ctr (CORO)
Spdr Series Trust State Street Spd (SPYM)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Columbia Etf Tr I Resh Enhnc Cor (RECS)
Blackrock Etf Trust Ishares A I Inno (BAI)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Scarborough Advisors

Top funds holding Lenz Therapeutics

RA Capital Management
FMR
Falcon Edge Capital
Versant Venture Management
BlackRock
Squarepoint Ops
Vanguard Group
Standard Life Aberdeen
Franklin Resources
Vanguard Capital Management
72 Investment Holdings
Millennium Management
CAM Group Holding A/S
Morgan Stanley
Bank of America Corporation

View all funds holding Lenz Therapeutics